Skip to main content
. 2021 Oct 8;100(40):e27368. doi: 10.1097/MD.0000000000027368

Figure 4.

Figure 4

Risk of herpes zoster with TNF-α inhibitors and non-TNF-α inhibitors compared with non-biological therapies. Compared with non-biological therapies, the risk of HZ increased significantly with use of TNF-α inhibitors (OR: 1.50; 95% CI: 1.11–2.02; I2 = 0%); no significant differences were observed with use of non-TNF-α inhibitors (OR: 1.20; 95% CI: 0.61–2.34; I2 = 0%). CI = confidence interval, HZ = herpes zoster, OR = odds ratio, TNF-α = tumor necrosis factor alpha.